Bea Van Der Gucht

447 total citations
8 papers, 324 citations indexed

About

Bea Van Der Gucht is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Bea Van Der Gucht has authored 8 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 2 papers in Emergency Medicine. Recurrent topics in Bea Van Der Gucht's work include HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). Bea Van Der Gucht is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (4 papers). Bea Van Der Gucht collaborates with scholars based in Belgium, Morocco and Australia. Bea Van Der Gucht's co-authors include Chris Verhofstede, Jean Plum, Filip Van Wanzeele, Nancy De Cabooter, Dirk Vogelaers, Linos Vandekerckhove, Jolanda Pelgrom, Kenny Dauwe, Els Demecheleer and Carole Seguin‐Devaux and has published in prestigious journals such as The Journal of Infectious Diseases, Virology and AIDS.

In The Last Decade

Bea Van Der Gucht

7 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bea Van Der Gucht Belgium 7 272 270 49 42 33 8 324
Rachanee Cheingsong United States 9 306 1.1× 332 1.2× 61 1.2× 62 1.5× 22 0.7× 9 380
Danielle Murray United States 3 242 0.9× 275 1.0× 46 0.9× 50 1.2× 48 1.5× 3 294
Margaret A Bedison United States 7 291 1.1× 343 1.3× 52 1.1× 65 1.5× 51 1.5× 8 376
Michael Belson United States 6 246 0.9× 281 1.0× 41 0.8× 79 1.9× 47 1.4× 7 320
Antonella d'Arminio-Monforte Italy 10 329 1.2× 331 1.2× 64 1.3× 23 0.5× 55 1.7× 14 387
Florence Damond France 7 244 0.9× 276 1.0× 69 1.4× 25 0.6× 19 0.6× 11 306
Sabine Kinloch-de-Loës United Kingdom 6 192 0.7× 206 0.8× 49 1.0× 44 1.0× 42 1.3× 6 246
Randall Tressler United States 7 219 0.8× 239 0.9× 75 1.5× 46 1.1× 90 2.7× 11 327
Brian Magambo Uganda 10 248 0.9× 252 0.9× 69 1.4× 26 0.6× 16 0.5× 14 302
María Inés Figueroa Argentina 10 286 1.1× 302 1.1× 81 1.7× 101 2.4× 82 2.5× 21 439

Countries citing papers authored by Bea Van Der Gucht

Since Specialization
Citations

This map shows the geographic impact of Bea Van Der Gucht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bea Van Der Gucht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bea Van Der Gucht more than expected).

Fields of papers citing papers by Bea Van Der Gucht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bea Van Der Gucht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bea Van Der Gucht. The network helps show where Bea Van Der Gucht may publish in the future.

Co-authorship network of co-authors of Bea Van Der Gucht

This figure shows the co-authorship network connecting the top 25 collaborators of Bea Van Der Gucht. A scholar is included among the top collaborators of Bea Van Der Gucht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bea Van Der Gucht. Bea Van Der Gucht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Scheerder, Marie‐Angélique De, Henrik Zetterberg, Dietmar Fuchs, et al.. (2020). Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption. Journal of Antimicrobial Chemotherapy. 75(5). 1311–1320. 13 indexed citations
2.
Degroote, Sophie, Dirk Vogelaers, Peter Vermeir, et al.. (2013). Socio‐economic, behavioural, (neuro)psychological and clinical determinants of HRQoL in people living with HIV in Belgium: a pilot study. Journal of the International AIDS Society. 16(1). 18643–18643. 45 indexed citations
3.
Dauwe, Kenny, Lander Foquet, Carole Seguin‐Devaux, et al.. (2011). Presence of CXCR4-Using HIV-1 in Patients With Recently Diagnosed Infection: Correlates and Evidence for Transmission. The Journal of Infectious Diseases. 205(2). 174–184. 64 indexed citations
4.
Wanzeele, Filip Van, Els Demecheleer, Kenny Dauwe, et al.. (2008). Impact of Δ32-CCR5 heterozygosity on HIV-1 genetic evolution and variability—A study of 4 individuals infected with closely related HIV-1 strains. Virology. 379(2). 213–222. 11 indexed citations
5.
Verhofstede, Chris, Filip Van Wanzeele, Bea Van Der Gucht, et al.. (2007). Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV‐1 viral rebounds of less than 1,000 RNA copies/ml. Journal of Medical Virology. 79(9). 1254–1260. 12 indexed citations
6.
Derdelinckx, Inge, Kristel Van Laethem, Ann De Roo, et al.. (2004). Prospective collection of data on the prevalence of transmitted resistance in newly diagnosed HIV-infected individuals in Belgium in 2003. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles).
7.
Verhofstede, Chris, Els Demecheleer, Nancy De Cabooter, et al.. (2004). Drug-Resistant Variants That Evolve During Nonsuppressive Therapy Persist in HIV-1–Infected Peripheral Blood Mononuclear Cells After Long-Term Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(5). 473–483. 50 indexed citations
8.
Verhofstede, Chris, Filip Van Wanzeele, Bea Van Der Gucht, Nancy De Cabooter, & Jean Plum. (1999). Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype. AIDS. 13(18). 2541–2546. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachanee Cheingsong Breakdown of academic impact, for papers by Danielle Murray Breakdown of academic impact, for papers by Margaret A Bedison Breakdown of academic impact, for papers by Michael Belson Breakdown of academic impact, for papers by Antonella d'Arminio-Monforte Breakdown of academic impact, for papers by Florence Damond Breakdown of academic impact, for papers by Sabine Kinloch-de-Loës Breakdown of academic impact, for papers by Randall Tressler Breakdown of academic impact, for papers by Brian Magambo Breakdown of academic impact, for papers by María Inés Figueroa
Rankless by CCL
2026